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The evidence associating red meat consumption and risk of multiple sclerosis is
inconclusive. We tested associations between red meat consumption and risk of a
first clinical diagnosis of central nervous system demyelination (FCD), often presaging
a diagnosis of multiple sclerosis. We used food frequency questionnaire data from the
2003–2006 Ausimmune Study, an incident, matched, case-control study examining
environmental risk factors for FCD. We calculated non-processed and processed red
meat density (g/1,000 kcal/day). Conditional logistic regression models (with participants
matched on age, sex, and study region) were used to estimate odds ratios (ORs), 95%
confidence intervals (95% CI) and p-values for associations between non-processed (n
= 689, 250 cases, 439 controls) and processed (n = 683, 248 cases, 435 controls)
red meat density and risk of FCD. Models were adjusted for history of infectious
mononucleosis, serum 25-hydroxyvitamin D concentrations, smoking, race, education,
body mass index and dietary misreporting. A one standard deviation increase in
non-processed red meat density (22 g/1,000 kcal/day) was associated with a 19%
reduced risk of FCD (AOR = 0.81; 95%CI 0.68, 0.97; p = 0.02). When stratified by
sex, higher non-processed red meat density (per 22 g/1,000 kcal/day) was associated
with a 26% reduced risk of FCD in females (n= 519; AOR= 0.74; 95%CI 0.60, 0.92; p=
0.01). There was no statistically significant association between non-processed red meat
density and risk of FCD inmales (n= 170). We found no statistically significant association
between processed red meat density and risk of FCD. Further investigation is warranted
to understand the important components of a diet that includes non-processed red meat
for lower FCD risk.
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INTRODUCTION
Diet is potentially a modifiable risk factor for multiple
sclerosis (MS); however, the current evidence in inconclusive.
The literature is somewhat consistent for higher intake of
fish and very long-chain omega-3 polyunsaturated fatty acids
(VLCn3PUFA: eicosapentaenoic acid, docosapentaenoic acid and
docosahexaenoic acid) and reduced risk of MS (1–4) Studies
investigating redmeat consumption and risk ofMS have returned
inconclusive results (4–10).
Non-processed red meat is an important dietary source of
protein, iron, zinc, vitamin B12, other minerals and vitamins,
and VLCn3PUFA (11). However, epidemiological studies have
linked higher red meat consumption with an increased risk
of various chronic diseases, including obesity, type 2 diabetes,
cardiovascular diseases and cancers. The findings have been
attributed largely to the fat content of red meat, and the
possible formation of carcinogenic compounds by cooking at
high temperatures (12). It has also been postulated that long-
term ingestion of N-glycolylneuraminic acid from consumption
of red meat may promote inflammation and cancer progression
(13), and may be a risk factor for MS (14). The strongest evidence
around red meat consumption and chronic diseases is for higher
processed meat intake and increased risk of colorectal cancer
(15) and all-cause mortality (16); similar associations with other
cancers have also been observed (17).
The 2003–2006 Australian Multi-center Study of
Environment and Immune Function (Ausimmune Study) was a
multi-center, case-control study examining associations between
environmental factors and risk of a first clinical diagnosis of CNS
demyelination (FCD) (18). Given that many people change their
diet when diagnosed with MS (19, 20), associating dietary factors
with risk of FCD offers the best opportunity to assess dietary
risk factors before disease-related changes in behavior occur. We
recently showed that a higher healthy dietary pattern score (high
in poultry, fish, eggs, vegetables, and legumes) was associated
with reduced risk of FCD in the Ausimmune Study (21). Also
in the Ausimmune Study, there was no evidence that saturated
or total fat intake in the preceding 12 months was associated
with an altered risk of FCD (2); however, fat intake was from
all dietary sources, and meat consumption was not specifically
investigated. To better understand the relationship between meat
consumption and risk of MS, we examined associations between
red meat consumption (non-processed and processed) and risk
of FCD in the Ausimmune Study.
METHODS
Study Design
The Ausimmune Study was conducted between November 2003
and December 2006 in four regions of Australia: Brisbane
city (latitude 27◦S), Newcastle region (33◦S), Geelong and
the Western districts of Victoria (37◦S), and the island of
Tasmania (43◦S) (18). Participants aged between 18 and 59
years and presenting with a FCD were notified to the study by
a range of clinicians including neurologists, ophthalmologists,
general physicians and, occasionally, general practitioners. Case
eligibility was reviewed by a study neurologist after notification
to the study (18). A study neurologist conducted a full history
and neurological examination, confirmed the date of onset,
and confirmed that the presenting symptoms indicated CNS
demyelination (18). A total of 282 case participants were
recruited, with a participation rate of 91% (22). Case participants
had had an incident FCD within the study period, among the
following types: a classic first demyelinating event (FDE; defined
as a single, first, episode of clinical symptoms suggestive of
CNS demyelination; n = 216); a first recognized event, but
past history revealed a prior event highly suggestive of CNS
demyelination (n= 48); first presentation of primary progressive
MS [based on neurological assessment on study entry (n =
18)]. Although some participants may have had a previous
undiagnosed demyelinating event, it is unlikely that a previous,
unrecognized, demyelinating event would have triggered changes
in dietary behavior.
We used the date of the MRI scan, which preceded the
diagnosis of FCD by only a few days and was available for most
case participants, as the date of diagnosis. Due to patient and
health care factors, there was a time lag from the date ofMRI scan
to study interview. For participants with dietary intake data, the
median [interquartile range (IQR)] time lag from the date of MRI
scan by the neurologist (the date of the diagnosis which brought
the participants into the study) to the study interview was 101
(147) days.
Control participants (n = 558) were randomly selected
from the general population via the Australian Electoral Roll
(compulsory registration for citizens ≥18 years). The control
participation rate was 60% of those contacted (22). Control
participants were matched to case participants based on age
(within 2 years), sex and study region. To maximize the study
power, between one and four matched controls were matched to
each case, with more controls per case in regions with a lower
expected number of cases. However, for practical reasons, these
ratios were altered during the course of the study so that all
centers were recruiting two controls per case in 2006.
The study was conducted in accordance with the Declaration
of Helsinki. Ethics approval was obtained from the nine
Human Research Ethics Committees of the participating
institutions, namely: Barwon Health Research and Ethics
Advisory Committee (ref 03/46); Ballarat Health Services and
St John of God Health Services Committee; Royal Brisbane
& Women’s Hospital & Health Service District Office of
the Human Research Ethics Committee (ref 2003/093);
The University of Queensland Medical Research Ethics
Committee (ref 2003000253); The Princess Alexandra Hospital
Human Research Ethics Committee (ref 2004/059); The
Queensland institute of Medical Research Human Research
Ethics Committee [ref H0511-061 (P950)]; Hunter Area
Research Ethics Committee (ref 03/06/11/3.07); Southern
Tasmania Heath and Medical Research Ethics Committee
(ref H7436); and The Australian National University Human
Research Ethics Committee (ref 2002/111). All participants
gave written informed consent for the use of their data. All
participant information was anonymized and de-identified prior
to analysis.
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Dietary Assessment
We used the Cancer Council Victoria Dietary Questionnaire
for Epidemiological Studies version 2 (DQESv2) to collect
information on habitual dietary intakes in the 12 months prior
to the study interview (23). The DQES is a self-administered,
semi-quantitative, food frequency questionnaire (FFQ) designed
for use in the ethnically-diverse adult Australian population. The
development of the DQES has been outlined in detail elsewhere
(24). In brief, the food list on the original FFQ was based on
weighed food records from 810 male and female volunteers, and
further developed in a sample of 17,949 healthy men and women
aged 40–69 years living in Melbourne, Australia (23).
The FFQ was validated relative to seven-day weighed
food records in 63 women of child-bearing age for an iron
supplementation study, where it performed as well as other
validated FFQs: mean intakes from the weighted food record and
the DQES were within±20% for 21 of 27 nutrients (25). The FFQ
is not recommended for children or younger people in general
(23), but is considered a suitable tool for assessing intakes of foods
and nutrients among adults in epidemiological studies, subject to
the limitations common to all FFQs (23).
The DQESv2 measured consumption of food items from four
groups: (1) cereals, sweets, and snacks; (2) dairy, meats, and
fish; (3) fruit; (4) vegetables. The frequencies of consumption of
food items were recorded according to the following scale: never,
less than once per month, one to three times per month, once
per week, twice per week, three to four times per week, five to
six times per week, once per day, twice per day, and three or
more times per day. Portion size diagrams of four commonly
consumed foods (potato, other vegetables, steak, casserole), were
used to determine respondents’ average portion size factor as
below median, median or above median (23). These portion size
factors were then used to scale standard portion sizes up or down
for different foods. Consumption of different types of alcoholic
drink was recorded, including the total number of glasses usually
drunk per day, and the maximum number of glasses drunk in
any 24 h during the past year. Consumption of each of 101
food and beverage items was reported as grams per day. Non-
processed red meat items reported from the FFQ were beef,
pork, veal and lamb, and processed red meat items were ham,
bacon, salami and sausage. Nutrient intakes for the DQESv2 were
computed primarily using composition data from the Australian
NUTTAB 95 database (26), with data for VLCn3PUFA derived
from the Royal Melbourne Institute of Technology fatty acid
database of Australian foods (27). Total energy intake (kcal/day)
was calculated from food and beverage intakes combined.
Covariates
Self-report questionnaires were used to collect information
on the following characteristics: race (Caucasian, other);
history of infectious mononucleosis (yes, no, don’t know);
total number of years smoking minus any periods of
abstinence; and highest education (year 10 or less, year 12
and Technical and Further Education, university). Most
participants (94%) provided a blood sample; serum aliquots
(1mL) were stored at −80◦C and analyzed at study completion
for 25-hydroxyvitamin D (25(OH)D) concentration (nmol/L)
using liquid chromatography tandem mass spectrometry (18).
Serum 25(OH)D concentrations for case participants were
de-seasonalized using the seasonal pattern of control serum
25(OH)D concentrations, to account for blood samples of cases
and controls being taken at different times of the year (18).
The study nurse measured height and weight, and body mass
index (BMI) was calculated as weight in kilograms divided by
height in meters squared. Basal metabolic rate was calculated
using the equations developed by Harris and Benedict (28):
males h = 66.4730+13.7516W+5.0033S−6.7750A; females h =
665.0955+9.5634W+1.8496S−4.6756A (where, h = kcal/day;
W = weight in kilograms; S = stature in centimeters; A
= age in years). Under-reporters were classified using the
Goldberg cut-off point of below BMRx1.05 (29). A two-category
variable was created for dietary misreporting: under-reporter and
plausible reporter.
Statistical Analysis
Of the 840 participants (282 cases, 558 controls) in the
Ausimmune Study, 791 participants provided dietary intake
data. We calculated non-processed (beef, veal, lamb, pork) and
processed (ham, bacon, salami, sausages) red meat density as
grams of meat intake per 1,000 kcal of energy intake per
day (g/1,000 kcal/day). Statistical outliers in non-processed and
processed red meat density were identified as those with values
as follows: 75th percentile + [3 × interquartile range (IQR)]
and 25th percentile-(3 × IQR). Three participants (two cases,
one control) had non-processed red meat density values above
the threshold of 132 g/1,000 kcal/day, and 10 participants (three
cases, 10 controls) had processed red meat density values above
the threshold of 50 g/1,000 kcal/day. These participants were
excluded from further analyses. Participants with missing data
for covariates were also excluded from further analyses. After
removing unmatched cases and controls, data for a total of 689
participants (250 cases, 439 controls) were available for non-
processed red meat analyses, and for 683 participants (248 cases,
435 controls) for processed red meat analyses.
Characteristics of case and control participants in the
current study were described as frequencies and percentages
for categorical variables, mean and standard deviation (SD)
for continuous variables with distributions resembling a
Normal distribution, and median and interquartile range (IQR)
for continuous variables with a non-Normal distribution.
Characteristics of control participants who were included in the
final model (n = 439 for non-processed red meat; n = 435
for processed red meat) were compared with those who were
excluded from the final model due to missing data or being
unmatched to a case participant (n = 119 for non-processed
red meat; n = 123 for processed red meat). Pearson’s chi-square
tests were used for categorical variables, independent samples
t-tests for continuous variables with Normal distributions, and
Mann-Whitney U tests for continuous variables with non-
Normal distributions.
We used conditional logistic regression models (with cases
and controls matched on age, sex and study region) to estimate
odds ratios (ORs), 95% confidence intervals (95% CI) and p-
values for associations between red meat density (non-processed
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and processed) and risk of FCD. We used non-processed and
processed red meat density as the continuous variable [per
standard deviation (SD)], withmodels conducted unadjusted and
adjusted for known environmental risk factors for MS (history
of infectious mononucleosis, serum 25(OH)D concentrations,
total years of smoking), potential risk factors for MS (race, BMI,
education) and dietary misreporting. We tested for non-linearity
using a quadratic term for non-processed and processed redmeat
density. Models were run in the total sample and also stratified by
sex. We investigated possible interactions between sex, red meat
density (non-processed and processed) and risk of FCD using a
multiplicative term.We tested whether any observed relationship
between non-processed red meat consumption and risk of FCD
was mediated by intakes of VLCn3PUFA by further adjusting
models for VLCn3PUFA density (g/1,000 kcal/day).
We conducted the following sensitivity analyses in the total
study sample and stratified by sex: (a) risk of FCD including
only participants with plausible energy intakes (>500 to <5,000
kcal/day); (b) risk of FCD in case participants who completed
the study interview within 90 days from the date of MRI scan
(in order to reduce the likelihood that participants had already
changed their diet in response to a FCD, noting that the FFQ
recorded data for the 12 months prior to the episode that brought
the case participant into the study); and (c) within the smaller




As expected, cases were more likely than controls to have a
history of infectious mononucleosis, lower serum 25(OH)D
concentrations and more years of smoking (Table 1). Median
non-processed red meat density was lower in cases than controls,
while there was no difference in median processed red meat
density between cases and controls (Table 1). Median non-
processed and processed red meat intake and density were higher
in males than females (Table 2).
There was no difference between the control participants who
were included in the main model for non-processed red meat
density (n = 439) and those who were excluded from the main
model (n = 119) with respect to the following characteristics:
history of infectious mononucleosis (p = 0.85), serum 25-
hydroxyvitamin D concentration (p = 0.14), total years of
smoking (p = 0.87), race (p = 0.30), age (p = 0.52), education
(p = 0.20), and BMI (p = 0.77). Compared with those excluded
from the main model of non-processed red meat density, control
participants included in the main model were more likely to be
male (p = 0.001) and to be from Brisbane or Tasmania (p <
0.001). For processed red meat, there was no difference between
the control participants who were included in the main model
(n = 435) and those who were excluded from the main model
(n = 123) with respect to the following characteristics: history of
infectious mononucleosis (p = 0.80), total years of smoking (p
= 0.59), race (p = 0.26), age (p = 0.62), education (p = 0.22),
and BMI (p = 0.39). Compared with those excluded from the
main model for processed red meat density, control participants
included in the main model were more likely to be male (p =
0.02), to be from Brisbane or Tasmania (p < 0.001), and to have
lower serum 25-hydroxyvitamin D concentrations (p= 0.04).
Non-processed Red Meat Density and Risk
of FCD
The test of a quadratic term for non-processed red meat density
indicated no evidence of non-linearity (p = 0.51). In the total
population, a one SD increase in non-processed red meat density
(22 g/1,000 kcal/day) was associated with a 19% reduced risk
of FCD in both unadjusted and adjusted models (Table 3). The
effect was strongest in females, with a 27% and 26% reduced risk
of FCD in unadjusted and adjusted models, respectively. There
was no evidence of an association between non-processed red
meat density and risk of FCD in males only. The interaction
between sex and non-processed red meat density was borderline
not statistically significant (p = 0.06). When further adjusted for
VLCn3PUFA density, there was little change in the estimated
effect of non-processed red meat density on risk of FCD (total
population, AOR= 0.81; 95%CI 0.68, 0.96; p= 0.02; males, AOR
= 1.08; 95%CI 0.72, 1.61; p = 0.71; females, AOR = 0.76; 95%CI
0.61, 0.94; p= 0.01).
Findings were similar to the main models when limited
to those with energy intakes within a plausible range (>500
to <5,000 kcal/day) (Table 4). The findings were also similar,
but with wider confidence intervals (as expected due to the
smaller sample size), in analyses limited to case participants who
completed the study interview within 90 days from the date of
MRI scan, and in those with a classic FDE (Table 4).
Processed Red Meat Density and Risk of
FCD
The test of a quadratic term for processed red meat density
indicated no evidence of non-linearity (p = 0.90). There was no
statistically significant association between processed red meat
density and risk of FCD in the total population, nor when
stratified by sex (Table 3). There was no statistically significant
interaction between sex and processed red meat density (p =
0.56). Sensitivity analyses showed similar findings to the main
models (Table 4).
DISCUSSION
Higher consumption of non-processed red meat was associated
with a reduced risk of FCD: a reduction of 19% per one
SD increase in non-processed red meat density. We found
no evidence of an association between processed red meat
consumption and risk of FCD. The findings were similar when
limited to those who completed the study interview within
90 days of their MRI scan, which reduces the likelihood that
participants were reporting on changes in their dietary behavior
in response to their diagnosis.
Red meat contains both VLCn3PUFA and vitamin D, low
levels of which have been associated with the risk and/or
progression of MS (2, 22, 31, 32). VLCn3PUFA play critical roles
in the central nervous system, exhibiting anti-inflammatory and
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TABLE 1 | Characteristics of participants in the Ausimmune Study included in the analysis for non-processed red meat (n = 689; 250 cases, 439 controls) and processed
red meat (n = 683; 248 cases, 435 controls).
Non-processed red meat Processed red meat
Case Control Case Control
SEX, % (n)1
Male 25.2 (63) 24.4 (107) 25.4 (63) 24.1 (105)
Female 74.8 (187) 75.6 (332) 74.6 (185) 75.9 (330)
Age, year, mean (SD)a 38.7 (9.7) 40.0 (9.6) 38.8 (9.7) 40.0 (9.6)
STUDY REGION, % (n)a
Brisbane (27◦S) 34.0 (85) 37.1 (163) 33.9 (84) 37.2 (162)
Newcastle (33◦S) 12.4 (31) 14.6 (64) 11.7 (29) 14.0 (61)
Geelong (37◦S) 23.6 (59) 24.4 (107) 24.2 (60) 24.6 (107)
Tasmania (43◦S) 30.0 (75) 23.9 (105) 30.2 (75) 24.1 (105)
Race, % (n) 94.1 (241) 94.1 (413) 96.4 (239) 94.0 (409)
Caucasian 3.6 (9) 5.9 (26) 3.6 (9) 6.0 (26)
OTHER
History of infectious mononucleosis, % (n)
No 65.2 (163) 79.3 (348) 64.9 (161) 79.3 (345)
Yes 28.0 (70) 16.2 (71) 28.2 (70) 16.1 (70)
Don’t know 6.8 (17) 4.6 (20) 6.9 (17) 4.6 (20)
Serum 25(OH)D concentrations (nmol/L), mean (SD) 75.8 (29.7) 81.9 (30.3) 75.8 (29.8) 81.5 (30.6)
Total years of smoking, median (IQR) 5.7 (18.7) 2.0 (14.8) 5.4 (18.9) 1.7 (14.7)
BODY MASS INDEX, MEDIAN (IQR)
Education, % (n)
Year 10 or less 24.8 (62) 33.3 (146) 25.0 (62) 33.3 (145)
Year 12 and tertiary and further education 50.0 (125) 41.7 (183) 49.2 (122) 41.2 (179)
University 25.2 (63) 25.1 (110) 25.8 (64) 25.5 (111)
Non-processed red meat intake (g/day), median (IQR) 46.5 (62.1) 58.7 (57.8) N/A N/A
Non-processed red meat density (g/1,000 kcal/day), median (IQR) 28.9 (28.2) 35.4 (27.4) N/A N/A
Processed red meat intake (g/day), median (IQR) N/A N/A 18.9 (22.6) 18.3 (22.1)
Processed red meat density (g/1,000 kcal/day), median (IQR) N/A N/A 11.1 (11.2) 11.0 (10.5)
DIETARY MISREPORTING, % (n)
Under-reporter 42.8 (107) 40.6 (178) 42.7 (106) 40.7 (177)
Plausible reporter 57.2 (143) 59.5 (261) 57.3 (142) 59.3 (258)
SD, standard deviation; 25(OH)D, 25-hydroxyvitamin D; IQR, interquartile range.
aCase and control participants were matched on sex, age (within 2 years) and study region.
neuro-protective effects (33). Indeed, we previously found that
higher intake of VLCn3PUFAwas associated with reduced risk of
FCD in the Ausimmune Study (2). Australian beef is commonly
from grass-fed livestock and has higher levels of VLCn3PUFA
compared to grain-fed beef (34); beef and lamb have previously
been shown to contribute 28% of the total VLCn3PUFA intake
in Australia (35). However, adjusting for VLCn3PUFA density
did not influence the effect estimate for non-processed red
meat density, suggesting an association between non-processed
red meat consumption and risk of FCD that is independent
of VLCn3PUFA.
Red meat also contains vitamin D and its hydroxylated form,
25(OH)D (36). The latter is considered to have five times the
bioactivity of vitamin D itself (37). Indeed, plasma 25(OH)D
concentrations were higher in meat eaters than in vegetarians
and vegans in a study of 2,107 British adults participating in the
European Prospective Investigation into Cancer and Nutrition
(EPIC)-Oxford cohort (38). Due to its frequency of consumption,
red meat is likely to be the most significant source of dietary
vitamin D in Australia (39). Since low vitamin D status is a
known risk factor for MS (22), we adjusted for serum 25(OH)D
concentrations, the major circulating form of vitamin D and
the product of both sun exposure and dietary intake of vitamin
D. Hence, our findings indicate an association between non-
processed red meat consumption and risk of FCD that is
independent of vitamin D.
When stratified by sex, the association between non-processed
red meat and risk of FCD was observed only in females. The
sample size for females was approximately 3 times greater than
that for males, reflecting the higher prevalence of MS in females
[approximately 2.5–3 times higher in females than males (40)].
Hence, the sex difference observed in our study may be a result
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TABLE 2 | Red meat intake (g/day) and density (g/1,000 kcal/day) for male and female participants in the Ausimmune Study included in the current study.
Males Females
n Case n Control n Case n Control
NON-PROCESSED RED MEAT
Intake (g/day), median (IQR) 63 87.4 (108.7) 107 79.4 (83.3) 187 39.1 (49.7) 332 54.2 (53.1)
Density (g/1,000 kcal/day), median (IQR) 63 38.6 (31.5) 107 36.5 (26.7) 187 26.9 (24.4) 332 35.05 (27.8)
PROCESSED RED MEAT
Intake (g/day), median (IQR) 63 29.4 (33.7) 105 27.3 (34.3) 185 15.9 (20.0) 330 16.9 (19.6)
Density (g/1,000 kcal/day), median (IQR) 63 12.6 (11.4) 105 12.0 (10.3) 185 10.3 (10.6) 330 10.4 (10.6)
TABLE 3 | Results from conditional logistic regressions models showing associations between red meat density (non-processed and processed) and risk of FCD in
participants of the Ausimmune Study included in the current study, in the total study sample and stratified by sex.
Unadjusted Adjusteda
n (cases, controls) OR (95% CI) P AOR (95% CI) P
NON-PROCESSED RED MEAT DENSITY (g/1,000 kcal/day, per SD)
Total 689 (250, 439) 0.81 (0.68, 0.95) 0.01 0.81 (0.68, 0.97) 0.02
Males 170 (63, 107) 1.06 (0.78, 1.45) 0.71 1.08 (0.73, 1.59) 0.69
Females 519 (187, 332) 0.73 (0.59, 0.89) 0.002 0.74 (0.60, 0.92) 0.01
PROCESSED RED MEAT DENSITY (g/1,000 kcal/day, per SD)
Total 683 (248, 435) 1.00 (0.85, 1.17) 0.98 1.04 (0.88, 1.22) 0.67
Males 168 (63, 105) 0.92 (0.68, 1.24) 0.59 0.92 (0.66, 1.29) 0.62
Females 515 (185, 330) 1.07 (0.87, 1.30) 0.53 1.10 (0.90, 1.35) 0.36
FCD, first clinical diagnosis of central nervous system demyelination; SD, standard deviation.
aAdjusted for history of infectious mononucleosis, serum 25-hydroxyvitamin D concentrations, total years of smoking, body mass index, race, education, and dietary misreporting.
of the substantially lower sample size for males. Alternatively, the
lack of effect in males might be explained by the existence of a
threshold intake of non-processed red meat consumption, above
which risk is reduced. For males, the median non-processed red
meat consumption for cases and their matched controls was 87
and 79 g/day, respectively, which was much greater than that
for females (39 g/day for cases, and 54 g/day for controls). It is
also plausible that we did not observe an association for males
because of insufficient exposure contrast between the male cases
and controls. The median difference in non-processed red meat
consumption between male cases and their matched controls was
8 g/day. This was less than that for females (median difference =
15 g/day).
An alternative explanation for the observed sex difference
relates to iron. From the onset of menarche until menopause,
females have greater iron requirements than males (41), and
nearly 40% of Australian females aged 14–50 years have
inadequate iron intakes (42). Red meat is high in haem iron (43),
which is more bioavailable than the plant form of iron (non-
haem) (44). Hence, low red meat consumption may compromise
iron status, and vegetarians (particularly female vegetarians)
are at high risk of iron deficiency (45). Dysregulation of iron
metabolism is implicated in MS, with degeneration of deep gray
matter structures corresponding with iron accumulation (46).
Conversely, iron levels may be reduced in the normal-appearing
white matter, with the extent of iron depletion correlating with
disease duration (47). There is no evidence of systematic iron
overload in people with MS (48, 49). Therefore, it has been
suggested that the iron dysregulation associated with MS is
a redistribution of iron levels between different areas of the
brain, rather than global iron accumulation (50). Iron sufficiency
may be important in preventing MS since iron is involved
in the synthesis, maintenance and repair of myelin, may be
critical to oligodendrocyte activity and integrity, and plays an
integral role in mitochondrial energy production (50). Indeed,
a recent analysis of pediatric MS patients and controls from the
United States (n = 312 cases; n = 456 controls) showed that low
iron intake was associated with an increased risk of MS (51).
The previous literature on meat consumption and risk of MS
is limited and mainly suggests an association between higher
processed red meat consumption and increased risk of MS
(Supplementary Table 1). In a 1992–1995 Canadian matched
case-control study, intakes of approximately 40 foods and
nutrients in the year prior to onset were estimated from a
food frequency questionnaire (4). Approximately 15 foods and
nutrients were significantly associated with increased risk of MS,
including processed meat; there was no statistically significant
association between beef consumption and risk of MS. A 1986–
1991 matched case-control study in Croatia showed that weekly
consumption (3–5 times/week) of a traditional meal of potatoes
with lard and smoked meat was associated with increased risk
of MS (5). This study was conducted in people with established
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TABLE 4 | Results from conditional logistic regressions models showing associations between red meat density (non-processed and processed) and (a) risk of FCD
including only participants with plausible energy intakes (>500 to <5,000 kcal/day), (b) risk of FCD in case participants who completed the study interview within 90 days




OR (95% CI) P AOR (95% CI) P
NON-PROCESSED RED MEAT DENSITY (g/1,000 kcal/day, per SD)
(a) risk of FCD including only participants with plausible energy intakes (>500–<5,000 kcal/day)
Total 676 (430, 246) 0.81 (0.69, 0.96) 0.02 0.82 (0.69, 0.98) 0.03
Males 161 (101, 60) 1.10 (0.80, 1.50) 0.57 1.14 (0.77, 1.70) 0.51
Females 515 (329, 186) 0.73 (0.59, 0.89) 0.002 0.74 (0.60, 0.92) 0.01
(b) risk of FCD in case participants who completed the study interview within 90 days from the date of MRI scan
Total 316 (115, 201) 0.86 (0.68, 1.08) 0.20 0.87 (0.67, 1.11) 0.26
Males 93 (34, 59) 1.28 (0.82, 2.01) 0.28 1.69 (0.90, 3.16) 0.10
Females 223 (81, 142) 0.71 (0.53, 0.96) 0.03 0.71 (0.52, 0.97) 0.03
(c) Risk of FDE
Total 519 (191, 328) 0.82 (0.68, 0.99) 0.04 0.80 (0.65, 0.98) 0.03
Males 129 (48, 81) 1.07 (0.75, 1.51) 0.72 1.07 (0.69, 1.66) 0.76
Females 390 (143, 247) 0.73 (0.58, 0.92) 0.01 0.71 (0.55, 0.92) 0.01
PROCESSED RED MEAT DENSITY (g/1,000 kcal/day, per SD)
(a) risk of FCD including only participants with plausible energy intakes (>500–<5,000 kcal/day)
Total 670 (426, 244) 1.00 (0.85, 1.18) 0.98 1.04 (0.88, 1.23) 0.64
Males 159 (99, 60) 0.93 (0.68, 1.27) 0.64 0.92 (0.64, 1.32) 0.65
Females 511 (327, 184) 1.03 (0.86, 1.24) 0.75 1.08 (0.89, 1.31) 0.45
(b) Risk of FCD in case participants who completed the study interview within 90 days from the date of MRI scan
Total 313 (114, 199) 1.00 (0.80, 1.25) 0.99 1.05 (0.82, 1.33) 0.70
Males 92 (34, 58) 1.00 (0.70, 1.43) 0.996 1.02 (0.64, 1.62) 0.93
Females 221 (80, 141) 1.00 (0.75, 1.32) 0.99 1.03 (0.76, 1.40) 0.83
(c) Risk of FDE
Total 518 (190, 328) 0.99 (0.83, 1.18) 0.89 1.02 (0.85, 1.23) 0.81
Males 128 (48, 80) 0.90 (0.66, 1.24) 0.53 0.94 (0.65, 1.35) 0.75
Females 390 (142, 248) 1.03 (0.83, 1.27) 0.80 1.06 (0.85, 1.33) 0.58
FCD, first clinical diagnosis of central nervous system demyelination; MRI, magnetic resonance imaging; FDE, incident classic first demyelinating event.
aAdjusted for history of infectious mononucleosis, serum 25-hydroxyvitamin D concentrations, total years of smoking, body mass index, race, education, and dietary misreporting.
MS, who had had MS for an average of 20 years, with only 9
participants showing no signs of disability, and food recall was
from birth until the first signs of the disease appeared. Hence,
our results are not comparable with that study.
A study by Lauer on 46 sociogeographic factors in the States
of America showed a positive correlation between meat sales
and incidence of MS (9); however, such ecological studies are
low on the hierarchy of evidence. Another ecological study by
Lauer using per capita meat consumption from 26 countries,
showed that sausage preservation by smoking was associated with
increased risk of MS (based on prevalence of MS from published
sources) (6). The association was independent of meat and pork
consumption (6). Lauer has suggested that the combination of
curing meats with nitrites and subsequent smoking produces
nitrophenylated compounds which conjugate with particular
proteins in the CNS (7). Although our study, and an analysis of
the Nurses’ Health Study and Nurses’ Health Study II (8), found
no association between processed meat consumption and risk of
FCD and MS, respectively, both studies assessed diet only in the
year preceding diagnosis. Consumption of smoked meat during
childhood and early adolescence may be more relevant to MS
onset than current dietary habits (7, 10) and was not assessed in
our study.
Our study has some important strengths compared with
previous studies assessing meat consumption and risk of MS.
We used a multi-center, matched case-control study design with
each case participant reviewed by the study neurologist, who
obtained a full clinical history and data from MRI scans. We
collected dietary data soon after diagnosis of FCD, which reduced
the likelihood that participants were reporting intakes based on
disease-related changes in dietary behavior. To further reduce
the possibility that the reported dietary intake was due to dietary
changes adopted as a result of their diagnosis, we also conducted
a sensitivity analysis in case participants interviewed within 90
days of their MRI scan; this was the shortest time interval that
retained a reasonable sample size. Due to the comprehensive
data collected in the Ausimmune Study, we were able to account
for the known environmental risk factors for MS, including
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serum 25(OH)D concentrations measured by an internationally-
standardized methodology (52). However, although we adjusted
for known and potential risk factors for MS, we cannot rule out
the possibility of residual confounding.
Although food frequency questionnaires are appropriate for
dietary intake assessment in epidemiological studies due to
their feasibility (both in terms of cost and participant burden),
the under-reporting of energy intake by self-reported dietary
methods is widely acknowledged (53). We, therefore, adjusted
for dietary misreporting and conducted a sensitivity analysis
including only participants with plausible energy intakes; this
returned very similar results to the main model.
A limitation of our study was the assessment of diet only in the
year prior to a FCD; it is possible that dietary habits in childhood
or adolescencemay influence later onset ofMS. Furthermore, our
results may not be generalizable to other populations: Australian
beef is commonly from grass-fed livestock and is likely to have
a different fat composition to beef from grain-fed livestock;
and participants in the Ausimmune Study were predominantly
Caucasian, and likely to follow dietary habits common to a
Caucasian population living in Australia.
A limitation of all FFQs is that not all food items are captured.
Consumption of game meats (e.g., kangaroo, goat, rabbit, and
venison) was not captured in the DQES. However, it is unlikely
that game meats were widely or frequently consumed; hence,
unlikely that the omission of game meats from the FFQ would
have influenced the results. Another limitation of the DQES is
that it has been validated only in females aged 16–48 years,
although it is widely used in epidemiological studies including
both males and females.
Since the control participation rate was 60% of those
contacted, the potential influence of selection bias must be
considered. As is commonly reported in studies with less than full
participation, the control sample was more highly educated than
the general population (e.g., 31% of control participants in the
Brisbane study region had completed university vs. 19% (54) of
the general population in that region). Similarly, the case sample
was more highly educated than the general population (e.g., 26%
of case participants in the Brisbane study region had completed
university vs. 19% (54) of the general population in that region).
After adjusting for age, sex and study region, there was no
statistically significant association between education level and
non-processed red meat density (results not shown); hence, it
is unlikely that any bias in education level would have affected
our findings with respect to non-processed red meat. There was
a statistically significant inverse association (p < 0.05) between
education level and processed meat density (results not shown).
However, had our control sample been more representative of
the general population (i.e., with lower education level), the effect
estimate would have been attenuated, with no likely effect on our
null findings.
In summary, our results suggest a reduced risk of FCD with
higher consumption of non-processed red meat. However, our
study does not elucidate the important components of non-
processed red meat that may be beneficial. It is important to note
that in order to enhance dietary variety and reduce some of the
health risks associated with consuming red meat, the maximum
number of weekly serves of lean red meat recommended for
Australian adults is seven (where one serve = 65 g) (55). In
general, young Australian women are advised to eat more red
meat, while Australian adult men need to eat less red meat
(56). With respect to FCD, further investigation is warranted to
understand the important components of a diet that includes
non-processed red meat. It is also not known whether non-
processed red meat consumption is associated with disease
progression in people with established MS.
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